DIA Europe 2020
29 Jun - 03 Jul 2020
Virtual
Menu Back to Committee

Meet the Programme Commitee for 2020!

Program Committee

  • Mathieu Boudes, PhD
    Mathieu Boudes, PhD • Consultant
    Montsouris Consilium, France
  • Sini Eskola, MPharm, MS, MSc
    Sini Eskola, MPharm, MS, MSc • Director Regulatory Affairs
    European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
  • Sabine Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Lenita Lindström-Gommers, LLM
    Lenita Lindström-Gommers, LLM • ICH Assembly Chair and Senior Expert, European Commission
    European Commission, Belgium
  • Kristin Raudsepp, MD
    Kristin Raudsepp, MD • Director General
    State Agency of Medicines, Estonia
  • Thomas Senderovitz, DrMed, MD
    Thomas Senderovitz, DrMed, MD • Senior Vice President, Data Science
    NovoNordisk, Denmark
  • Chris Walker, MSc
    Chris Walker, MSc • Vice President, Head of Regulatory Affairs for Europe, Latin America, Middle Eas
    Amgen, United Kingdom
  • Sabine Atzor, MPharm, RPh
    Sabine Atzor, MPharm, RPh • Head of EU Regulatory Policies
    F. Hoffmann-La Roche Ltd, Switzerland
  • Michael Berntgen, PhD
    Michael Berntgen, PhD • Head of Scientific Evidence Generation
    European Medicines Agency, Netherlands
  • Michelle Bridenbaker, BSN, MS
    Michelle Bridenbaker, BSN, MS • Head of Global Medical Information
    Idorsia Pharmaceuticals Ltd, Switzerland
  • Nikolai Constantin Brun, MD
    Nikolai Constantin Brun, MD • Co-Chair, EMA-MHA Big Data Task Force; Dir, Div for Medical Eval & Biostatistics
    Danish Medicines Agency, Denmark
  • Ursula Busse, PhD, MBA
    Ursula Busse, PhD, MBA • Head of Regulatory Intelligence & Policy
    Boehringer Ingelheim, Germany
  • Anthony Humphreys, MPharm
    Anthony Humphreys, MPharm • Head of the Regulatory Science and Innovation Task Force
    European Medicines Agency, Netherlands
  • Claudio Lorck
    Claudio Lorck • Associate Director Regulatory Policy & Intelligence
    Abbvie Deutschland Gmbh & Co. KG, Germany
  • Katarzyna Swiderek, MPharm, RPh
    Katarzyna Swiderek, MPharm, RPh • Director, Safety Evaluation Risk Management (SERM)
    GlaxoSmithKline, Poland
  • Elena Prokofyeva, MD, PhD, MPH
    Elena Prokofyeva, MD, PhD, MPH • Head of Drug Safety Unit, Department of Research & Development, DG PRE
    Federal Agency for Medicines and Health Products (FAMHP), Belgium
  • Anja Schiel, PhD
    Anja Schiel, PhD • Senior Adviser/Statistician, Unit for HTA and Reimbursement
    Norwegian Medicines Agency (NoMA), Norway
  • Gerhard Schlueter, DrSc, PhD, MSc
    Gerhard Schlueter, DrSc, PhD, MSc • Head of Strategic and Technical Operations, Regulatory Affairs
    Bayer AG, Germany
  • Elke Stahl, PhD
    Elke Stahl, PhD • CTFG Co-Chair, Clinical Trials expert
    Federal Institute For Drugs and Medical Devices (BfArM), Germany
  • Aimad Torqui
    Aimad Torqui • Executive Director Global Regulatory Policy
    MSD, Netherlands
  • Timothy Wilsdon, MS
    Timothy Wilsdon, MS • Principal
    Charles River Associates International, United Kingdom
  • Maria Wishart
    Maria Wishart • Medical Director, Global Patient Safety
    Astrazeneca, United Kingdom
Load More